Clinical and research tests for 137215 - Genetic Testing Registry (GTR) - NCBI

Warning: The NCBI web site requires JavaScript to function. more...

<< First< Prev

Page 1 of 9

Results: 1 to 20 of 170

Tests names and labs	Conditions	Genes, analytes, and microbes	Methods
Gastric cancer risk after H. pylori infection, 137215, Autosomal dominant (Hereditary diffuse gastric cancer) (IL1RN gene) (Sequence Analysis-All Coding Exons) (Postnatal) Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey	1	1	C Sequence analysis of the entire coding region
Gastric cancer, familial diffuse, with or without cleft lip and/or palate, 137215, Autosomal dominant (Hereditary diffuse gastric cancer) (MLPA) Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey	1	1	D Deletion/duplication analysis
Gastric cancer, familial diffuse, with or without cleft lip and/or palate, 137215, Autosomal dominant (Hereditary diffuse gastric cancer) (CDH1 gene) (Sequence Analysis-All Coding Exons) (Postnatal) Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey	1	1	C Sequence analysis of the entire coding region
Gastric cancer, somatic, 137215 (KRAS gene) (Sequence Analysis-All Coding Exons) (Postnatal) Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey	1	1	C Sequence analysis of the entire coding region
Gastric cancer risk after H. pylori infection, 137215, Autosomal dominant (Hereditary diffuse gastric cancer) (IL1B gene) (Sequence Analysis-All Coding Exons) (Postnatal) Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey	1	1	C Sequence analysis of the entire coding region
Expedio Hereditary Cancer Predisposition Screening Assay Kailos Genetics United States	40	31	C Sequence analysis of the entire coding region
Hereditary Cancer Panel Comprehensive Molecular Genetics Laboratory London Health Sciences Centre Canada	39	30	D Deletion/duplication analysis C Sequence analysis of the entire coding region T Targeted variant analysis
OnkoRisk Hereditary Oncology Plus Panel BioReference Health United States	97	77	C Sequence analysis of the entire coding region
OnkoRisk Hereditary Oncology Management Panel BioReference Health United States	47	17	C Sequence analysis of the entire coding region
OnkoRisk Women's Hereditary Cancer Panel BioReference Health United States	34	18	C Sequence analysis of the entire coding region
OnkoRisk Hereditary Urology Panel BioReference Health United States	27	19	C Sequence analysis of the entire coding region
Hereditary Cancer Screening - Breast Cancer Panel (19 Genes) Genesys Diagnostics Genesys Diagnostics, Inc. United States	22	19	X Mutation scanning of select exons
Hereditary Cancer Screening - Colorectal & Gastric Cancer Panel (including Pancreatic Cancer) - (43 Genes) Genesys Diagnostics Genesys Diagnostics, Inc. United States	58	43	X Mutation scanning of select exons
Hereditary Cancer Screening - Common Hereditary Cancer Panel (41 Genes) Genesys Diagnostics Genesys Diagnostics, Inc. United States	47	41	X Mutation scanning of select exons
Hereditary Cancer Screening - Breast & Gynecological Cancer Panel (33 Genes) Genesys Diagnostics Genesys Diagnostics, Inc. United States	37	33	X Mutation scanning of select exons
Hereditary Cancer Screening - Full Hereditary Cancer Panel (99 Genes) Genesys Diagnostics Genesys Diagnostics, Inc. United States	109	99	X Mutation scanning of select exons
CDH1 Full Gene Analysis Mayo Clinic Laboratories Mayo Clinic United States	1	1	C Sequence analysis of the entire coding region
Hereditary diffuse gastric cancer (CDH1 gene) Molecular Genetics and Cytogenetics, Clinical Laboratory Service RED DE SALUD UC CHRISTUS Chile	1	1	C Sequence analysis of the entire coding region
PREVENTEST GeneID Lab - Advanced Molecular Diagnostics United States	60	34	D Deletion/duplication analysis C Sequence analysis of the entire coding region
Otogenetics Hereditary Cancers Otogenetics United States	36	39	E Sequence analysis of select exons

<< First< Prev

Page 1 of 9

Results: 1 to 20 of 170

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.